Self-association of cyclodextrins and cyclodextrin complexes

被引:365
作者
Loftsson, T
Másson, M
Brewster, ME
机构
[1] Univ Iceland, Fac Pharm, IS-107 Reykjavik, Iceland
[2] Div Janssen Pharmaceut NV, Pharmacuet Res & Dev, B-2340 Beerse, Belgium
关键词
cyclodextrin; self-association; complexation; non-inclusion; aggregates; phase-solubility; solubilization;
D O I
10.1002/jps.20047
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclodextrins are useful functional excipients, which are being used in an ever-increasing way to camouflage undesirable pharmaceutical characteristics, especially poor aqueous solubility. It has generally been assumed that the mechanism whereby cyclodextrins exert their effects, especially their augmentation of solubility, is via the formation of noncovalent, dynamic inclusion complexes. This is a model, which regards drug-cyclodextrin interactions as a discrete phenomenon and ignores the possible interaction of these complexes with one another. It is becoming increasingly apparent that such assumptions may not be universally applicable or all encompassing. Specifically, there is a growing body of evidence that supports the important contribution of non-inclusion-based aspects for drug solubilization by cyclodextrins including surfactant-like effects and molecular aggregation. This short review attempts to assess the available literature for areas in which such non-inclusion mechanisms are apparent and tries to interpret these in the context of a broader working theory as to how cyclodextrins exert their beneficial effects. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:1091 / 1099
页数:9
相关论文
共 59 条
[1]   EXTENDED 2,5-DIPHENYLOXAZOLE-GAMMA-CYCLODEXTRIN AGGREGATES EMITTING 2,5-DIPHENYLOXAZOLE EXCIMER FLUORESCENCE [J].
AGBARIA, RA ;
GILL, D .
JOURNAL OF PHYSICAL CHEMISTRY, 1988, 92 (05) :1052-1055
[2]   PHASE-TRANSITION PATTERN OF 2,5-DIPHENYLOXAZOLE/GAMMA-CYCLODEXTRIN (PPO/GAMMA-CD) SELF-ASSEMBLY AGGREGATES [J].
AGNEW, KA ;
MCCARLEY, TD ;
AGBARIA, RA ;
WARNER, IM .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 1995, 91 (03) :205-210
[3]   NMR spectroscopic evidence and molecular dynamics studies on inclusion and non-inclusion phenomena between beta-cyclodextrin and new anti-Alzheimer's drugs tacrine (CI-970), velnacrine (HP-029) and suronacrine (HP-128) [J].
Amato, ME ;
Lipkowitz, KB ;
Lombardo, GM ;
Pappalardo, GC .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1996, (03) :321-325
[4]   Inclusion compounds of psychotropic agents and cyclodextrins [J].
Andronati, SA ;
Shapiro, YE ;
Yakubovskaya, LN ;
Gorbatyuk, VY ;
Andronati, KS ;
Krasnoschekaya, SP .
JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, 1996, 24 (1-2) :175-186
[5]  
AOYAMA Y, 1992, TETRAHEDRON LETT, V33, P3775, DOI 10.1016/S0040-4039(00)92011-2
[6]   A NEW PH-METRIC METHODOLOGY FOR THE DETERMINATION OF THERMODYNAMIC INCLUSION CONSTANTS OF GUEST CYCLODEXTRIN COMPLEXES [J].
BOUDEVILLE, P ;
BURGOT, JL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (09) :1083-1089
[7]  
Brewster ME, 1999, INJECTABLE DRUG DEV, P307
[8]   THERMODYNAMIC STUDY ON THE EFFECTS OF BETA-CYCLODEXTRIN INCLUSION WITH ANILINONAPHTHALENESULFONATES [J].
CATENA, GC ;
BRIGHT, FV .
ANALYTICAL CHEMISTRY, 1989, 61 (08) :905-909
[9]   Study of inclusion complexes of acridine with β- and (2,6-di-O-methyl)-β-cyclodextrin by use of solubility diagrams and NMR spectroscopy [J].
Correia, I ;
Bezzenine, N ;
Ronzani, N ;
Platzer, N ;
Beloeil, JC ;
Doan, BT .
JOURNAL OF PHYSICAL ORGANIC CHEMISTRY, 2002, 15 (09) :647-659
[10]   Cyclodextrins and emulsions [J].
Duchêne, D ;
Bochot, A ;
Yu, SC ;
Pépin, C ;
Seiller, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 266 (1-2) :85-90